| Elizabeth Pinkerton, | |
|
1212 Koger Center Blvd, North Chesterfield, VA 23235-4778 | |
| (804) 897-2100 | |
| Not Available |
| Full Name | Elizabeth Pinkerton |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1212 Koger Center Blvd, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255996286 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101277690 (Virginia) | Primary |
| Entity Name | Virginia Physicians For Women, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639137979 PECOS PAC ID: 8628057924 Enrollment ID: O20040720000074 |
News Archive
The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper's authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.
Agfa HealthCare Corp. announced today a new collaboration with OnBase to integrate the "gold standards" in enterprise imaging and enterprise content management technologies to showcase the vast potential of a fully integrated, "document + image" electronic health record (EHR).
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Pinkerton, 1212 Koger Center Blvd, North Chesterfield, VA 23235-4778 Ph: (804) 897-2100 | Elizabeth Pinkerton, 1212 Koger Center Blvd, North Chesterfield, VA 23235-4778 Ph: (804) 897-2100 |
News Archive
The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper's authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.
Agfa HealthCare Corp. announced today a new collaboration with OnBase to integrate the "gold standards" in enterprise imaging and enterprise content management technologies to showcase the vast potential of a fully integrated, "document + image" electronic health record (EHR).
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 3 days ago
Mary Lynn Coble, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 807-897-9074 | |
Garrett Michael Wren, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 | |
Kristen Lawson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 | |
Kimberly W Mcmorrow, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 | |
Molly E Ashby Jackson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 | |
Kenley W Neuman, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Koger Center Blvd, North Chesterfield, VA 23235 Phone: 804-897-2100 Fax: 804-897-9074 |